QR kód

Pembrolizumab-Induced Simultaneous and Refractory Systemic Capillary Leak and Cytokine Release Syndromes: A Case Report

Systemic Capillary Leak Syndrome (SCLS) and Cytokine Release Syndrome (CRS) have both been described as rare but severe adverse reactions induced by Programmed cell death protein 1 (PD-1) inhibitors such as pembrolizumab. We report the case of a 40-year-old woman undergoing treatment with pembrolizu...

Celý popis

Uloženo v:
Hlavní autoři: Eugénie Roberge-Maltais, Eric Lévesque, Vincent Castonguay, Nicolas Marcoux, Louis-Philippe Grenier, Martin Veilleux
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2025-08-01
Edice:Current Oncology
Témata:
capillary leak syndrome
cytokine release syndrome
immune checkpoint inhibitors
PD-1 inhibitors
ruxolitinib
axitinib
On-line přístup:https://www.mdpi.com/1718-7729/32/8/469
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky